← Back
$PTHS All transactions

Pelthos Therapeutics Inc.

C

$ Value

$0

Shares

15,000

Price

$0

Filed

Jul 3

Insider

Name

LIGAND PHARMACEUTICALS INC

Title

CIK

0000886163

Roles

10% Owner

Transaction Details

Transaction Date

2025-07-01

Code

C

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

3,000

Footnotes

The numbers reported herein have been adjusted to reflect the 1-for-10 reverse stock split effected by the Issuer on July 1, 2025. | Received in exchange for shares of LNHC, Inc. common stock in connection with the merger of CHRO Merger Sub, Inc. ("Merger Sub"), a wholly owned subsidiary of the Issuer, with and into LNHC, Inc., a wholly-owned subsidiary of the reporting person, with LNHC continuing as a wholly-owned subsidiary of the Issuer and the surviving corporation of the merger, pursuant to the Merger Agreement, dated as of April 16, 2025, by and among the Issuer, Merger Sub, LNHC, and solely for the purposes of Article III thereof, the reporting person. | The Series A convertible preferred stock is convertible at any time, at the holder's election, and has no expiration date. The Series A convertible preferred stock is subject to a contractual limitation such that the reporting person may not convert Series A convertible preferred stock to the extent that after giving effect to such conversion, the reporting person (together with its attribution parties as defined in the certificate of designations) would beneficially own in excess of 49.9% of the shares of common stock outstanding immediately after giving effect to such conversion.

Filing Info

Accession No.

0000950170-25-093589

Form Type

4

Issuer CIK

0001919246

LIGAND PHARMACEUTICALS INC's History

Date Ticker Type Value
2025-12-17 PTHS D
2025-12-17 PTHS A
2025-11-06 PTHS A
2025-07-01 PTHS C $15.0M
2025-07-01 PTHS C $0
2025-07-01 PTHS J

Other Insiders at PTHS (90d)

Insider Bought Sold Last
Greenleaf Peter $17K 2026-04-02
Davis Todd C 2025-07-02
Francis Knuettel II
CFO, Treas & Secty
2025-07-02
Pauls Matthew $16K 2026-04-02
Friedberg Ezra M $12K 2026-04-02
Plesha Scott M.
CEO and President
2025-07-02
Malamut Richard $12K 2026-04-02
Baxter Richard B 2025-07-02
Rangarao Sai
Chief Commercial Officer
2025-07-02